← Browse by Condition
Medical Condition

blood pressure monitoring

Total Trials
2
Recruiting Now
2
Trial Phases
Phase 3

ClinicalMetric tracks all active clinical trials for blood pressure monitoring sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 3
1
Top Sponsors
Mount Sinai Hospital, Canada 1 trial
Centre Hospitalier de Saint-Denis 1 trial

Recruiting Clinical Trials

NCT07294950 Phase 3
Recruiting

Impact of Semaglutide Withdrawal on Cardiometabolic Profile and Physiology of Energy Balance: Recovery Effects After Semaglutide Termination

Enrollment
98 pts
Location
Canada
Sponsor
Mount Sinai Hospital, Canada
View Trial →
NCT07052123
Recruiting

Non-Invasive Blood Pressure Monitoring in ICU Patients Using the DARE Device

Enrollment
2 pts
Location
France
Sponsor
Centre Hospitalier de Saint-De...
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology